tradingkey.logo

Rapid Micro Biosystems Inc

RPID
3.740USD
-0.130-3.36%
交易中 美东报价延迟15分钟
165.72M总市值
亏损市盈率 TTM

Rapid Micro Biosystems Inc

3.740
-0.130-3.36%

关于 Rapid Micro Biosystems Inc 公司

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc简介

公司代码RPID
公司名称Rapid Micro Biosystems Inc
上市日期Jul 15, 2021
CEOSpignesi (Robert)
员工数量163
证券类型Ordinary Share
年结日Jul 15
公司地址25 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02421
电话19783493200
网址https://www.rapidmicrobio.com/
公司代码RPID
上市日期Jul 15, 2021
CEOSpignesi (Robert)

Rapid Micro Biosystems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14300.00%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+14300.00%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+14300.00%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14300.00%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+14300.00%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+14300.00%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product revenue
4.84M
61.74%
Service revenue
3.00M
38.26%
地区USD
名称
营收
占比
United States
2.85M
36.43%
Germany
1.58M
20.15%
Switzerland
1.39M
17.67%
All other countries
1.10M
14.09%
Japan
915.00K
11.67%
业务
地区
业务USD
名称
营收
占比
Product revenue
4.84M
61.74%
Service revenue
3.00M
38.26%

股东统计

更新时间: 1月2日 周五
更新时间: 1月2日 周五
持股股东
股东类型
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
10.24%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
其他
45.87%
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
10.24%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
其他
45.87%
股东类型
持股股东
占比
Investment Advisor
37.25%
Venture Capital
10.30%
Investment Advisor/Hedge Fund
6.65%
Corporation
5.67%
Hedge Fund
4.22%
Individual Investor
3.85%
Private Equity
1.45%
Research Firm
0.11%
其他
30.50%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Bain Capital Life Sciences Investors, LLC
8.43M
21.18%
--
--
Sep 30, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.4%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
8.93%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.67%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.64%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
965.02K
2.42%
+60.66K
+6.71%
Sep 30, 2025
Parkman Healthcare Partners LLC
913.44K
2.29%
--
--
Sep 30, 2025
Schonfeld Strategic Advisors LLC
646.58K
1.62%
-391.09K
-37.69%
Sep 30, 2025
Advent International L.P.
577.78K
1.45%
--
--
Sep 30, 2025
Spignesi (Robert G JR)
498.32K
1.25%
+4.39K
+0.89%
Oct 17, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
占比0.02%
Dimensional US Core Equity 1 ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI